Urol. praxi. 2024;25(2):88-92 | DOI: 10.36290/uro.2024.036

A psychiatric patient in a urologist's office

MUDr. Jiří Poněšický
Privátní urologická praxe Královské Vinohrady, s. r. o., Praha
Psychiatrická nemocnice Bohnice, Praha
Adiktologická klinika 1. LF UK a VFN, Praha

Psychiatric diseases are very common in the population, which is why even a urologist regularly encounters them in his office. Psychiatric diseases can have urological symptoms and some psychotropic drugs can cause urological symptoms. Urological disease can have an impact on mental health. Urological medications can affect psychiatric illness. Psychiatric and urological issues can overlap. Some psychiatric patients may be more difficult to communicate with.

Keywords: depression, anxiety, psychotropic drugs, antidepressants, antipsychotics.

Accepted: May 31, 2024; Published: June 20, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Poněšický J. A psychiatric patient in a urologist's office. Urol. praxi. 2024;25(2):88-92. doi: 10.36290/uro.2024.036.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10: 1289-1298. Go to original source... Go to PubMed...
    2. Národní akční plán pro duševní zdraví 2020-2030, Ministerstvo zdravotnictvíČR, Dostupné z: https://www.mzcr.cz/wp- content/uploads/wepub/18368/40091/02_Priloha%202_Analytick%C3%A1%20%C4%8D%C3%A1st.pdf.
    3. Peyronnet B, Mironska E, Chapple C, et al. Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988-1000. Go to original source... Go to PubMed...
    4. Praško J. Úzkostné poruchy. Klasifikace, diagnostika a léčba. Praha: Portal; 2005.
    5. Lai HH, Rawal A, Shen B, et al. The Relationship Between Anxiety and Overactive Bladder or Urinary Incontinence Symptoms in the Clinical Population. Urology. 2016;98:50-57. Go to original source... Go to PubMed...
    6. Thüroff JW, Abrams P, Andersson KE et al. EAU guidelines on urinary incontinence. Eur Urol. 2011;59(3):387-400. Go to original source... Go to PubMed...
    7. Končelíková D. Močová retence jako vzácná komplikace užívání psychofarmak. Urol. praxi. 2021;22(4):192-194. Go to original source...
    8. Veale D, Miles S, Read J, et al. Penile Dysmorphic Disorder: Development of a Screening Scale. Arch Sex Behav. 2015;44(8):2311-2321. Go to original source... Go to PubMed...
    9. Trinchieri M, Perletti G, Magri V, et al. Urinary side effects of psychotropic drugs: A systematic review and metanalysis. Neurourol Urodyn. 2021;40(6):1333-1348. Go to original source... Go to PubMed...
    10. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259-266. Go to original source... Go to PubMed...
    11. Schifano M, Boeri L, Pozzi E, et al. Medications mostly associated with priapism events: Assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries. Eur Urol. 2021;79:S651-S652. Go to original source...
    12. Crump C, Stattin P, Brooks JD, et al. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study. Eur Urol. 2023;84(3):263-272. Go to original source... Go to PubMed...
    13. Klaassen Z, Wallis CJD. Addressing Mental Health in Urology Patients: The Time is Now. Eur Urol Focus. 2020;6(6): 1137-1139. Go to original source... Go to PubMed...
    14. Campbell NL, Maidment I, Fox C, et al. The 2012 update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61(Suppl.1):S142-S143.
    15. Egberts A, van der Craats ST, van Wijk MD, et al. Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients. Pharmacol Res Perspect. 2017;5(3):e00310. Go to original source... Go to PubMed...
    16. Siebert AL, Lapping-Carr L, Morgans AK. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician. Eur Urol Focus. 2020;6(6):1170-1179. Go to original source... Go to PubMed...
    17. Mahjoob DM, Janssen JMW, van Koeveringe GA, et al. Psychiatric disorders in patients with lower urinary tract symptoms: A systematic review including a subgroup meta-analysis on the association between LUTS and depressive symptoms. Continence. 2023;6(1):100589. Go to original source...
    18. Engeler D, Messelink EJ, Almeida Pinto R, et al. EAU Guidelines. Chronic Pelvic Pain. EAU Guidelines Office, Arnhem, the Netherlands. Available from: http://uroweb.org/guidelines/compilations-of-all-guidelines/-MANAGEMENT-Uroweb (https://uroweb.org/guidelines/chronic-pelvic-pain/chapter/management>).
    19. Kamarádová D, Látalová K, Hejda M. Problémový pacient v ambulanci urologa. Urol. praxi. 2016;17(4):180-182. Go to original source...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.